The purpose of this study is to characterize the circadian rhythm disruption experienced by patients as determined by plasma melatonin, cortisol, and other circadian analytes
Age range
6 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Circadian melatonin rhythm as measured by plasma melatonin
Timeframe: 36-hour blood sampling on week 1
Circadian melatonin rhythm as measured by plasma melatonin
Timeframe: 36-hour blood sampling on week 2
Circadian melatonin rhythm as measured by plasma melatonin
Timeframe: 36-hour blood sampling on week 4
Circadian cortisol rhythms as measured by plasma cortisol
Timeframe: 36-hour blood sampling at week 1
Circadian cortisol rhythms as measured by plasma cortisol
Timeframe: 36-hour blood sampling at week 2
Circadian cortisol rhythms as measured by plasma cortisol
Timeframe: 36-hour blood sampling at week 4
Circadian analytes rhythms as measured in plasma
Timeframe: 36-hour blood sampling at week 1
Circadian analytes rhythms as measured in plasma
Timeframe: 36-hour blood sampling at week 2
Circadian analytes rhythms as measured in plasma
Timeframe: 36-hour blood sampling at week 4